Shabnam Arsiwala
Medical Director
Dr. Shabnam Arsiwala, MD is the Medical Director of the Sickle Cell Disease Program at Children’s Mercy Kansas City, with a dedicated clinical and academic focus on sickle cell disease and thalassemia. Her work emphasizes improving outcomes across the lifespan for individuals with inherited blood disorders through innovative, patient-centered care models that address both medical and psychosocial complexities.
Dr. Arsiwala has a particular interest in transition care, designing and implementing programs that support adolescents and young adults as they move from pediatric to adult health systems. She is actively engaged in advancing care delivery through multidisciplinary collaboration across hematology, cardiology, and behavioral health, and contributes to initiatives evaluating eligibility for emerging therapies, including cellular and gene-based treatments.
In addition to her clinical leadership, Dr. Arsiwala contributes to educational and advocacy initiatives aimed at improving awareness and standards of care for individuals with sickle cell disease and thalassemia globally. Her interests include innovative care models and equitable access to advanced therapies.
